Cargando…
A simple reverse genetics method to generate recombinant coronaviruses
Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we de...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066064/ https://www.ncbi.nlm.nih.gov/pubmed/35239997 http://dx.doi.org/10.15252/embr.202153820 |
_version_ | 1784699724928909312 |
---|---|
author | Mélade, Julien Piorkowski, Géraldine Touret, Franck Fourié, Toscane Driouich, Jean‐Sélim Cochin, Maxime Bouzidi, Hawa Sophia Coutard, Bruno Nougairède, Antoine de Lamballerie, Xavier |
author_facet | Mélade, Julien Piorkowski, Géraldine Touret, Franck Fourié, Toscane Driouich, Jean‐Sélim Cochin, Maxime Bouzidi, Hawa Sophia Coutard, Bruno Nougairède, Antoine de Lamballerie, Xavier |
author_sort | Mélade, Julien |
collection | PubMed |
description | Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we describe a simple method based on “infectious subgenomic amplicons” (ISA) technology to generate recombinant infectious coronaviruses with no need for reconstruction of the complete genomic cDNA and apply this method to SARS‐CoV‐2 and also to the feline enteric coronavirus. In both cases we rescue wild‐type viruses with biological characteristics similar to original strains. Specific mutations and fluorescent red reporter genes can be readily incorporated into the SARS‐CoV‐2 genome enabling the generation of a genomic variants and fluorescent reporter strains for in vivo experiments, serological diagnosis, and antiviral assays. The swiftness and simplicity of the ISA method has the potential to facilitate the advance of coronavirus reverse genetics studies, to explore the molecular biological properties of the SARS‐CoV‐2 variants, and to accelerate the development of effective therapeutic reagents. |
format | Online Article Text |
id | pubmed-9066064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90660642022-05-04 A simple reverse genetics method to generate recombinant coronaviruses Mélade, Julien Piorkowski, Géraldine Touret, Franck Fourié, Toscane Driouich, Jean‐Sélim Cochin, Maxime Bouzidi, Hawa Sophia Coutard, Bruno Nougairède, Antoine de Lamballerie, Xavier EMBO Rep Reports Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we describe a simple method based on “infectious subgenomic amplicons” (ISA) technology to generate recombinant infectious coronaviruses with no need for reconstruction of the complete genomic cDNA and apply this method to SARS‐CoV‐2 and also to the feline enteric coronavirus. In both cases we rescue wild‐type viruses with biological characteristics similar to original strains. Specific mutations and fluorescent red reporter genes can be readily incorporated into the SARS‐CoV‐2 genome enabling the generation of a genomic variants and fluorescent reporter strains for in vivo experiments, serological diagnosis, and antiviral assays. The swiftness and simplicity of the ISA method has the potential to facilitate the advance of coronavirus reverse genetics studies, to explore the molecular biological properties of the SARS‐CoV‐2 variants, and to accelerate the development of effective therapeutic reagents. John Wiley and Sons Inc. 2022-03-03 /pmc/articles/PMC9066064/ /pubmed/35239997 http://dx.doi.org/10.15252/embr.202153820 Text en © 2022 Unité des Virus Emergents. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reports Mélade, Julien Piorkowski, Géraldine Touret, Franck Fourié, Toscane Driouich, Jean‐Sélim Cochin, Maxime Bouzidi, Hawa Sophia Coutard, Bruno Nougairède, Antoine de Lamballerie, Xavier A simple reverse genetics method to generate recombinant coronaviruses |
title | A simple reverse genetics method to generate recombinant coronaviruses |
title_full | A simple reverse genetics method to generate recombinant coronaviruses |
title_fullStr | A simple reverse genetics method to generate recombinant coronaviruses |
title_full_unstemmed | A simple reverse genetics method to generate recombinant coronaviruses |
title_short | A simple reverse genetics method to generate recombinant coronaviruses |
title_sort | simple reverse genetics method to generate recombinant coronaviruses |
topic | Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066064/ https://www.ncbi.nlm.nih.gov/pubmed/35239997 http://dx.doi.org/10.15252/embr.202153820 |
work_keys_str_mv | AT meladejulien asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT piorkowskigeraldine asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT touretfranck asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT fourietoscane asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT driouichjeanselim asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT cochinmaxime asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT bouzidihawasophia asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT coutardbruno asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT nougairedeantoine asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT delamballeriexavier asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT meladejulien simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT piorkowskigeraldine simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT touretfranck simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT fourietoscane simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT driouichjeanselim simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT cochinmaxime simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT bouzidihawasophia simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT coutardbruno simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT nougairedeantoine simplereversegeneticsmethodtogeneraterecombinantcoronaviruses AT delamballeriexavier simplereversegeneticsmethodtogeneraterecombinantcoronaviruses |